The tumor-infiltrating DCs, particularly CD103+ cDC1s, were essential for eliciting CD8+ T cell responses [9], and the abundance cDC1 in tumors could be used to predict responsiveness to anti-PD-1 blockade [30]. The gene discussed is ITGAE; the disease is neoplasm.